Machine Learning-Based Virtual Screening, Molecular Docking, Drug-Likeness, Pharmacokinetics And Toxicity Analyses To Identify New Natural Inhibitors Of The Glycoprotein Spike (S1) Of Sars-Cov-2
AuthID
P-016-BR6
P-016-BR6
